Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.39 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12216668 | 0.92 | GAA (0.39) | GAATSHRALDH1A1APPMCL1 | |
| SCHEMBL13943136 | 0.84 | GAA (0.54) | GAATSHRALDH1A1APPMCL1 | |
| SCHEMBL12153959 | 0.84 | GAA (0.54) | GAATSHRALDH1A1APPMCL1 | |
| SCHEMBL12715267 | 0.82 | GAA (0.42) | GAATSHRALDH1A1MCL1NPSR1 | |
| SCHEMBL14562186 | 0.78 | GAA (0.57) | GAATSHRALDH1A1APPMCL1 | |
| SCHEMBL13967099 | 0.78 | GAA (0.36) | GAATSHRALDH1A1APPMCL1 | |
| SCHEMBL12715139 | 0.77 | APP (0.43) | APP | |
| SCHEMBL13943828 | 0.77 | ALDH1A1 (0.39) | GAATSHRALDH1A1APPTHRB | |
| SCHEMBL14224660 | 0.77 | — | — | |
| SCHEMBL12715212 | 0.74 | ALDH1A1 (0.35) | ALDH1A1APPNPSR1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7924697-B2 | Optical information recording medium, image-recording method and method of utilizing a dye | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-7924697-B2 | Optical information recording medium, image-recording method and method of utilizing a dye | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20090092024-A1 | OPTICAL INFORMATION RECORDING MEDIUM, IMAGE-RECORDING METHOD AND METHOD OF UTILIZING A DYE | FUJIFILM CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090092024-A1 | OPTICAL INFORMATION RECORDING MEDIUM, IMAGE-RECORDING METHOD AND METHOD OF UTILIZING A DYE | FUJIFILM CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20080090174-A1 | Novel Oxonol Dye Compounds and Optical Information Recording Medium | FUJIFILM CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| US-7238461-B2 | Optical information-recording medium, novel oxonol compound and method of recording information | FUJIFILM CORPORATION (JP) | 2007-07-03 | — | — | US | disclosed |
| US-20070020562-A1 | Optical information-recording medium, novel oxonol compound and method of recording information | FUJI PHOTO FILM CO., LTD. | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090174-A1 | Novel Oxonol Dye Compounds and Optical Information Recording Medium | KCNB1, KCNMB1, HCN2 | GAA 3423/4885TSHR 4629/4885ALDH1A1 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.